Ginkgo Bioworks Holdings Stock Probability of Future Stock Price Finishing Over 8.79
| DNA Stock | USD 8.79 0.82 8.53% |
Ginkgo |
Ginkgo Bioworks Target Price Odds to finish over 8.79
The tendency of Ginkgo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.79 | 90 days | 8.79 | about 34.2 |
Based on a normal probability distribution, the odds of Ginkgo Bioworks to move above the current price in 90 days from now is about 34.2 (This Ginkgo Bioworks Holdings probability density function shows the probability of Ginkgo Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 3.03 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ginkgo Bioworks will likely underperform. Additionally Ginkgo Bioworks Holdings has an alpha of 0.5078, implying that it can generate a 0.51 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ginkgo Bioworks Price Density |
| Price |
Predictive Modules for Ginkgo Bioworks
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ginkgo Bioworks Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ginkgo Bioworks Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ginkgo Bioworks is not an exception. The market had few large corrections towards the Ginkgo Bioworks' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ginkgo Bioworks Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ginkgo Bioworks within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.51 | |
β | Beta against Dow Jones | 3.03 | |
σ | Overall volatility | 1.13 | |
Ir | Information ratio | 0.09 |
Ginkgo Bioworks Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ginkgo Bioworks for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ginkgo Bioworks Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ginkgo Bioworks had very high historical volatility over the last 90 days | |
| Ginkgo Bioworks has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 251.46 M. Reported Net Loss for the year was (892.87 M) with profit before taxes, overhead, and interest of 273.49 M. | |
| Ginkgo Bioworks Holdings has about 1.32 B in cash with (295.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from telegraph.co.uk: Christopher Columbus did not take syphilis to the Americas he brought it back to Europe, DNA shows |
Ginkgo Bioworks Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ginkgo Stock often depends not only on the future outlook of the current and potential Ginkgo Bioworks' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ginkgo Bioworks' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.6 M | |
| Cash And Short Term Investments | 944.1 M |
Ginkgo Bioworks Technical Analysis
Ginkgo Bioworks' future price can be derived by breaking down and analyzing its technical indicators over time. Ginkgo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ginkgo Bioworks Holdings. In general, you should focus on analyzing Ginkgo Stock price patterns and their correlations with different microeconomic environments and drivers.
Ginkgo Bioworks Predictive Forecast Models
Ginkgo Bioworks' time-series forecasting models is one of many Ginkgo Bioworks' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ginkgo Bioworks' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ginkgo Bioworks Holdings
Checking the ongoing alerts about Ginkgo Bioworks for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ginkgo Bioworks Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ginkgo Bioworks had very high historical volatility over the last 90 days | |
| Ginkgo Bioworks has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 251.46 M. Reported Net Loss for the year was (892.87 M) with profit before taxes, overhead, and interest of 273.49 M. | |
| Ginkgo Bioworks Holdings has about 1.32 B in cash with (295.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Ginkgo Bioworks has a poor financial position based on the latest SEC disclosures | |
| Roughly 68.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from telegraph.co.uk: Christopher Columbus did not take syphilis to the Americas he brought it back to Europe, DNA shows |
Check out Ginkgo Bioworks Backtesting, Ginkgo Bioworks Valuation, Ginkgo Bioworks Correlation, Ginkgo Bioworks Hype Analysis, Ginkgo Bioworks Volatility, Ginkgo Bioworks History as well as Ginkgo Bioworks Performance. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.89) | Revenue Per Share 4.291 | Quarterly Revenue Growth 0.606 | Return On Assets (0.21) | Return On Equity (0.64) |
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.